(5-Methoxypyridin-3-yl)methanamine dihydrochloride, 97%, 250mg

Methyl 2,6-dichloro-5-iodopyrimidine-4-carboxylate, 98+%, 5g

tert-Butyl (Z)-(3-fluoro-2-(hydroxymethyl)allyl)carbamate, 98%, 1g

Cyclopropyl methyl ketone, 98.0%, 25g

1,2-Dimyristoyl-sn-glycero-3-phosphocholine>97.0%(HPLC)(T)1g

N-(4-Cyclopropyl-6-ethylpyrimidin-2-yl)-5-fluorobenzofuran-2-carboxamide, 98%, 250mg

DL-Méthionine, min.99%, pour la biochimie, 500 g, emballage plastique.

(S)-1-(3,4-Difluorophenyl)ethanamine hydrochloride, 95.0%, 250mg

Seringue microlitre GASTIGHT® série 1700 Point type 3, 10 µl, 1701 RNR, 1 pièce

(4-((2-Methoxy-2-oxoethyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

Bekanamycin, 98%, 500mg

Diethoxyacetonitrile, 97.0%, 25g

Ethyl 3-bromopropiolate, 95.0%, 1g